Pfizer (BOG:PFECO) Long-Term Debt: COP219,926,341 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOG:PFECO Pfizer Inc BOG:PFECO
70 GF Score
Price COP95,840.00
GF Value COP99,518.78
! 5 Warning Signs
View Full Analysis

What is Pfizer Long-Term Debt?

Pfizer BOG:PFECO 70 Long-Term Debt is COP219,926,341 Mil as of Mar. 2026. GuruFocus rates BOG:PFECO with a GF Score™ of 70/100 and a GF Value™ of COP99,518.78. The stock has 5 warning signs investors should review.

Pfizer's Long-Term Debt for the quarter that ended in Mar. 2026 was COP219,926,341 Mil.

Pfizer's quarterly Long-Term Debt increased from Sep. 2025 (COP221,599,885 Mil) to Dec. 2025 (COP227,446,149 Mil) but then declined from Dec. 2025 (COP227,446,149 Mil) to Mar. 2026 (COP219,926,341 Mil).

Pfizer's annual Long-Term Debt increased from Dec. 2023 (COP242,318,477 Mil) to Dec. 2024 (COP251,414,297 Mil) but then declined from Dec. 2024 (COP251,414,297 Mil) to Dec. 2025 (COP227,446,149 Mil).

Pfizer  (BOG:PFECO) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Pfizer Long-Term Debt Related Terms

Pfizer Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Pfizer's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Long-Term Debt Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 136,984,303.78 152,261,191.97 242,318,477.43 251,414,296.87 227,446,148.60

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 234,429,635.01 228,526,923.44 221,599,884.94 227,446,148.60 219,926,340.85
BOG:PFECO
70GF Score
Pfizer Inc BOG:PFECO
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of COP219,926,341 Mil mean?
Pfizer (BOG:PFECO) has a Long-Term Debt of COP219,926,341 Mil as of Mar. 2026.
Is Pfizer's Long-Term Debt too high?
Pfizer's current Long-Term Debt is COP219,926,341 Mil. Overall, Pfizer has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Long-Term Debt compare to BMY and GILD?
Pfizer's Long-Term Debt of COP219,926,341 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Pfizer's current Long-Term Debt is COP219,926,341 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Pfizer (BOG:PFECO) has a current Long-Term Debt of COP219,926,341 Mil. The stock's GF Value™ is COP99,518.78, compared to a current price of COP95,840.00 — trading 3.7% below its estimated fair value. The current Long-Term Debt is COP219,926,341 Mil. Pfizer's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Pfizer (BOG:PFECO), the current Long-Term Debt is COP219,926,341 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (BOG:PFECO) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of COP95,840.00 is trading 3.7% below its estimated GF Value™ of COP99,518.78.

Key valuation signals for BOG:PFECO:

  • Long-Term Debt: COP219,926,341 Mil
  • GF Value™: COP99,518.78 vs. price of COP95,840.00 (3.7% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the BOG:PFECO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
70GF Score

Get the complete analysis for BOG:PFECO

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

COP95,840.00
Price
COP99,518.78
GF Value